Anti-OR2J3/ 6M1-3/ C3HEXS monoclonal antibody

Anti-OR2J3/ 6M1-3/ C3HEXS antibody for FACS & in-vivo assay

Target products collectionGo to OR2J3/OR2J3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1048-Ab-1/ GM-Tg-hg-MP1048-Ab-2Anti-Human OR2J3 monoclonal antibodyHuman
GM-Tg-rg-MP1048-Ab-1/ GM-Tg-rg-MP1048-Ab-2Anti-Rat OR2J3 monoclonal antibodyRat
GM-Tg-mg-MP1048-Ab-1/ GM-Tg-mg-MP1048-Ab-2Anti-Mouse OR2J3 monoclonal antibodyMouse
GM-Tg-cynog-MP1048-Ab-1/ GM-Tg-cynog-MP1048-Ab-2Anti-Cynomolgus/ Rhesus macaque OR2J3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1048-Ab-1/ GM-Tg-felg-MP1048-Ab-2Anti-Feline OR2J3 monoclonal antibodyFeline
GM-Tg-cang-MP1048-Ab-1/ GM-Tg-cang-MP1048-Ab-2Anti-Canine OR2J3 monoclonal antibodyCanine
GM-Tg-bovg-MP1048-Ab-1/ GM-Tg-bovg-MP1048-Ab-2Anti-Bovine OR2J3 monoclonal antibodyBovine
GM-Tg-equg-MP1048-Ab-1/ GM-Tg-equg-MP1048-Ab-2Anti-Equine OR2J3 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1048-Ab-1/ GM-Tg-hg-MP1048-Ab-2; GM-Tg-rg-MP1048-Ab-1/ GM-Tg-rg-MP1048-Ab-2;
GM-Tg-mg-MP1048-Ab-1/ GM-Tg-mg-MP1048-Ab-2; GM-Tg-cynog-MP1048-Ab-1/ GM-Tg-cynog-MP1048-Ab-2;
GM-Tg-felg-MP1048-Ab-1/ GM-Tg-felg-MP1048-Ab-2; GM-Tg-cang-MP1048-Ab-1/ GM-Tg-cang-MP1048-Ab-2;
GM-Tg-bovg-MP1048-Ab-1/ GM-Tg-bovg-MP1048-Ab-2; GM-Tg-equg-MP1048-Ab-1/ GM-Tg-equg-MP1048-Ab-2
Products NameAnti-OR2J3 monoclonal antibody
Formatmab
Target NameOR2J3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OR2J3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species OR2J3/ 6M1-3/ C3HEXS VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1048
    Target NameOR2J3
    Gene ID442186
    Gene Symbol and Synonyms6M1-3,C3HEXS,HS6M1-3,OR2J3,OR6-16,OR6-6,OR6.3.6,ORL671
    Uniprot AccessionO76001
    Uniprot Entry NameOR2J3_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000204701
    Target ClassificationN/A

    The target: OR2J3, gene name: OR2J3, also named as 6M1-3, C3HEXS, HS6M1-3, OR6-16, OR6-6, OR6.3.6, ORL671. This gene encodes a G-protein-coupled receptor (GPCR) that functions as an olfactory receptor. Olfactory receptors interact with odorant molecules in the nose to initiate a neuronal response that triggers the perception of a smell. The protein encoded by this gene responds to cis-3-hexen-1-ol, which is released by wounded plants, including cut grass. This gene is situated in a cluster of similar olfactory-receptor coding genes on chromosome 6. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.